Search results
Byju's is in big trouble - ET LegalWorld
The Economic Times· 3 days agoByju Raveendran on July 25 moved a fresh writ petition in Karnataka High Court for suspension of the order admitting Byju's parent Think and Learn...
NEET PG 2024 Admit Card: NEET Exam City Slip Releasing Today on natboard.edu.in
Times Now· 10 hours agoNEET PG 2024 Admit card will be out on August 8 and exam city slip is due to be released today. NEET...
PM Narendra Modi bullish on tourist footfall in Charaideo Maidam in Upper Assam
The Telegraph· 12 hours agoPrime Minister Narendra Modi on Sunday exhorted tourists to include Charaideo Maidam in Upper Assam...
Alzheimer’s Disease: Some trials to watch over the next year
Clinical Trials Arena· 1 hour agoIn the experimental arm, patients receive 265mg oral valiltramiprosate, twice per day. The second...
Jefferies initiates coverage on Adani Green Energy with buy rating, sees 18% upside
The Economic Times· 10 hours agoIn its coverage initiation, Jefferies highlighted the Khavda 30 GW execution as a key game-changer...
NCLAT judge recuses from hearing Raveendran's plea against insolvency proceedings of Byju | Business...
Business Insider India· 9 hours agoRaveendran had filed a petition challenging the initiation of insolvency proceedings against Think & Learn, which runs edtech company Byju's.
Budget proposes steps to reduce litigation, 'Vivad Se Vishwas' scheme 2.0 in offing - The Economic...
The Economic Times· 6 days agoNew Delhi: To reduce litigation, the Budget on Tuesday proposed to come out with 'Vivad Se Vishwas'...
Ola Electric IPO; Rapido truns unicorn
The Economic Times· 3 hours agoE-scooter maker Ola Electric’s much-awaited IPO, the country’s biggest this year, is set to hit the markets on Friday. Electric two-wheeler manufacturer...
Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on...
CNBC Awaaz· 23 hours agoUltraTech Cement, Maruti Suzuki India, Sun Pharma Advanced Research Company, Glenmark Life Sciences,...
ProMIS Neurosciences reports results for Phase Ia trial of Alzheimer’s treatment
Clinical Trials Arena· 8 hours agoThe trial's initiation was based on nonclinical studies that highlighted PMN310's selective...
